Navigation Links
CareFusion Corp to be Included in S&P 500 Index

SAN DIEGO, Aug. 25 /PRNewswire-FirstCall/ -- CareFusion Corporation announced today that its stock will be included in the S&P 500 index following the company's planned spinoff from Cardinal Health on Aug. 31. CareFusion stock will be added to the index on Sept. 1, coinciding with its first day of regular-way trading on the New York Stock Exchange under the symbol "CFN."

"Our inclusion in the S&P 500 is a testament to our position in the industry as we launch a new public company dedicated to helping hospitals improve patient care and safety, both domestically and around the world," said David Schlotterbeck, chief executive officer of CareFusion. "We are pleased to be recognized among such a select group of U.S. companies."

CareFusion provides products and services designed to help measurably improve patient care in two major areas: medication errors and hospital-acquired infections. The company's common stock began trading on a "when issued" basis on Aug. 21. On Aug. 31, "when issued" trading is scheduled to end and "regular way" trading is scheduled to begin on Sept. 1 under the ticker symbol "CFN."

Regarded as one of the best single gauges of the U.S. equities market, the S&P 500 index includes 500 leading companies in leading industries of the U.S. economy.

About CareFusion Corporation

CareFusion Corporation is currently a wholly owned subsidiary of Cardinal Health (NYSE: CAH). The global company serves the health care industry with products and services that help hospitals measurably improve the safety and quality of care. CareFusion develops market-leading technologies including Alaris(R) IV pumps, Pyxis(R) automated dispensing and patient identification systems, AVEA(R) and Pulmonetic Systems(TM) ventilation and respiratory products, ChloraPrep(R) for infection prevention and MedMined(TM) services for infection surveillance, neurological monitoring and diagnostic products, V. Mueller(R) surgical instruments and an extensive line of products that support interventional medicine.

CareFusion employs more than 15,000 people across its global operations. The company has been authorized to have its shares of common stock listed on the New York Stock Exchange under the ticker symbol "CFN." More information may be found at

Cautions concerning forward-looking statements

This news release contains forward-looking statements addressing the planned spinoff of the clinical and medical products businesses of Cardinal Health as a separate company named CareFusion Corporation, which is dependent upon future events or developments. These matters are subject to risks and uncertainties that could cause actual events (including the planned spinoff) and results to differ materially from those projected, anticipated or implied. These risks and uncertainties include uncertainties regarding the planned spinoff of CareFusion, including the timing and terms of such spinoff and whether such spinoff will be completed as it is subject to a number of conditions. In addition, Cardinal Health and CareFusion are subject to additional risks and uncertainties described in CareFusion's Form 10, as amended, and Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those filings and reports. Except to the extent required by applicable law, Cardinal Health and CareFusion undertake no obligation to update or revise any forward-looking statement.

SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CareFusion Issues Update Regarding Previously Disclosed June 12, 2009 Recall of the Alaris(R) System
2. CareFusion Form 10 Registration Statement Declared Effective
3. CareFusion Expands Pyxis(R) Perioperative Solutions Offering
4. CareFusion Prices $1.4 Billion of Senior Notes
5. Cardinal Health Board of Directors Approves CareFusion Spinoff
6. CareFusion to Resume Shipping Alaris(R) Infusion Products
7. CareFusion Corporation Launches International Jazz Festival Series
8. CareFusion Files Amended Form 10 Registration Statement With SEC
9. CareFusion Launches New Brand, Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety
10. CareFusion Names Robert Friel to Board of Directors
11. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... ORANGE COUNTY, Calif. , Oct. 10, 2017  NDS received ... Mobile  — a medical-grade battery-powered display stand specifically designed for ... aims to transform technology into a clinical solution to support the ... costs. Innovative Design ... NDS ZeroWire Mobile Wireless Solution ...
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
(Date:10/4/2017)... Oct. 4, 2017 OBP Medical ... illuminating medical devices, today announced regulatory approval from ... Agency (or Agência Nacional de Vigilância Sanitária (ANVISA)) ... cordless surgical retractor with integrated LED light source ... illumination and exposure of a tissue pocket or ...
Breaking Medicine Technology: